Study of Epratuzumab in Systemic Lupus Erythematosus
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Epratuzumab is an investigational antibody designed to help treat SLE. The purpose is to
evaluate safety and long term efficacy in concert with standard SLE treatments